Inovio Pharmaceuticals's market cap is currently $77.61M. The company's EPS TTM is $-4.484; its P/E ratio is ―; Inovio Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 832.01K	$ 10.26M	$ 1.77M	$ 7.41M	$ 4.11M
Gross Profit	$ -2.67M	$ 4.77M	$ -2.96M	$ -86.83M	$ -83.91M
Operating Income	$ -143.94M	$ -267.57M	$ -301.22M	$ -124.08M	$ -111.11M
EBITDA	$ -130.39M	$ -270.90M	$ -296.56M	$ -149.56M	$ -107.34M
Net Income	$ -135.12M	$ -287.66M	$ -305.38M	$ -215.09M	$ -120.55M
Balance Sheet
Cash & Short-Term Investments	$ 145.29M	$ 253.00M	$ 401.31M	$ 411.64M	$ 89.53M
Total Assets	$ 170.95M	$ 348.53M	$ 495.94M	$ 539.77M	$ 143.95M
Total Debt	$ 30.21M	$ 32.07M	$ 33.02M	$ 39.05M	$ 99.51M
Net Debt	$ 15.90M	$ -14.25M	$ -38.12M	$ -211.68M	$ 77.31M
Total Liabilities	$ 53.60M	$ 126.17M	$ 96.27M	$ 78.63M	$ 138.55M
Stockholders' Equity	$ 117.35M	$ 222.36M	$ 399.67M	$ 461.14M	$ 3.44M
Cash Flow
Free Cash Flow	$ -124.69M	$ -217.18M	$ -216.94M	$ -179.50M	$ -98.84M
Operating Cash Flow	$ -124.37M	$ -216.22M	$ -215.71M	$ -177.98M	$ -97.85M
Investing Cash Flow	$ 87.36M	$ 109.59M	$ -175.34M	$ -58.80M	$ -9.04M
Financing Cash Flow	$ 5.00M	$ 81.84M	$ 211.50M	$ 465.28M	$ 105.40M

Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History

Income Statement >

Inovio Pharmaceuticals Debt to Assets

Balance Sheet >

Inovio Pharmaceuticals Cash Flow

Cash Flow >

Inovio Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing